Stock News
“ON Semiconductor Delivers Strong Fourth Quarter and Full Year 2024 Results: A Look at the Company’s Impressive Performance”
Welcome to the World of onsemi Fourth Quarter and Fiscal Year 2024 Results SCOTTSDALE, Ariz.–(BUSINESS WIRE)–onsemi (the “Company”) (Nasdaq: ON) today announced its fourth quarter and fiscal year 2024 results with some impressive highlights: Fourth Quarter Highlights: – Revenue of $1,722.5 million – GAAP gross margin of 45.2% – Non-GAAP gross margin of 45.3% –…
“Neumora Therapeutics Inc. Faces Securities Fraud Class Action Lawsuit: What You Need to Know”
Neumora Therapeutics, Inc. Lawsuit: What You Need to Know Introduction Recently, if you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment, you may have the opportunity for potential recovery under the federal securities laws. This news has gained attention in the investment community, prompting investors to seek more information. Background Neumora Therapeutics, Inc….
“Breaking News: Caribou Biosciences Inc. Faces Class Action Lawsuit – What You Need to Know”
Suffered a Loss on Your Caribou Biosciences, Inc. Investment? Potential Recovery under Federal Securities Laws If you find yourself in a situation where you have suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment, there may be hope for a potential recovery under the federal securities laws. It is crucial to understand your rights…
“Attention Newmont Investors: Don’t Miss Out on This Class Action Reminder from Levi and Korsinsky!”
*Back in the bustling city of New York, where dreams are made and fortunes are lost, a recent announcement has caused quite a stir in the financial world. If you’re one of the unfortunate individuals who suffered a loss on your investment in Newmont Corporation (NYSE:NEM), there may be a glimmer of hope for a…
“Attention Shareholders: Don’t Miss Your Chance to Lead the Way with Levi and Korsinsky – Important Deadline Reminder!”
Regeneron Pharmaceuticals, Inc. Investment Loss Recovery New York, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information or contact Joseph E. Levi, Esq….
Pediatrix Medical Group’s 2024 Fourth Quarter Conference Call and Webcast: A Charming and Engaging Event for Readers!
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)—- $MD–Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025. Embracing Charmingly Eccentric and Engaging Designs As we look forward to the Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast scheduled for Thursday, February 20, 2025, one can’t help but appreciate the charm and personality that the…
“Proxy Powerhouse: Glass Lewis Teams Up with ISS and Egan-Jones to Back Barington Capital’s Dream Team at Matthews International!”
Potential Shake-Up at Matthews – Glass Lewis vs. Barington A Battle for Shareholder Support In a recent development at Matthews, Glass Lewis, a leading proxy advisor, has come out with scathing criticism against the current management of the company. According to Glass Lewis, Matthews has “persistently deteriorated and consistently underperformed during substantially all measurement periods,…
“Attention BioA Investors: Don’t Miss Out on This Exciting News! Bronstein, Gewirtz & Grossman LLC Has the Inside Scoop!”
Investors Beware: Class Action Lawsuit Filed Against BioAge Labs, Inc. New York City, NY / Access Newswire / February 10, 2025 Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ:BIOA) and certain of its officers….